Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients.

  • 2004-01
  • Life sciences 74(7)
    • Ximing Liu
    • Junping Wei
    • Fengsen Tan
    • Shengming Zhou
    • Gudrun Würthwein
    • Peter Rohdewald

Study Design

Type
Randomized Controlled Trial (RCT)
Sample size
n = 58
Population
58 patients with hypertension
Methods
Placebo-controlled, double-blind, parallel group study; 100 mg Pycnogenol for 12 weeks
Blinding
Double-blind
Duration
12 weeks
Funding
Unclear
A placebo-controlled, double-blind, parallel group study was performed with 58 patients to investigate effects of French maritime pine bark extract, Pycnogenol, on patients with hypertension. Supplementation of the patients with 100 mg Pycnogenol over a period of 12 weeks helped to reduce the dose of the calcium antagonist nifedipine in a statistically significant manner. The intake of Pycnogenol decreased endothelin-1 concentrations significantly compared to placebo while concentrations of 6-keto prostaglandin F1a in plasma were significantly higher compared to placebo. Values for nitric oxide (NO) in plasma increased in both groups, but the differences were not significant. Angiotensin II concentrations in plasma were lowered in the placebo group to a larger extent than in the Pycnogenol group. Heart rate, electrolytes and blood urea nitrogen were not changed during treatment in both groups of patients. Unwanted effects observed in both groups were of mild and transient nature, such as gastrointestinal problems, vertigo, headache and nausea. Differences in rate of side effects were not statistically significant between the two groups. Study results support a supplementation with Pycnogenol for mildly hypertensive patients.

Research Insights

  • concentrations of 6-keto prostaglandin F1a in plasma were significantly higher compared to placebo

    Effect
    Beneficial
    Effect size
    Small
    Dose
    100 mg/day
  • Values for nitric oxide (NO) in plasma increased in both groups, but the differences were not significant

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 mg/day
  • Angiotensin II concentrations in plasma were lowered in the placebo group to a larger extent than in the Pycnogenol group.

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 mg/day
  • Heart rate, electrolytes and blood urea nitrogen were not changed during treatment in both groups of patients.

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 mg/day
  • Heart rate, electrolytes and blood urea nitrogen were not changed during treatment in both groups of patients.

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 mg/day
  • The intake of Pycnogenol decreased endothelin-1 concentrations significantly compared to placebo

    Effect
    Beneficial
    Effect size
    Small
    Dose
    100 mg/day
  • Heart rate, electrolytes and blood urea nitrogen were not changed during treatment in both groups of patients.

    Effect
    Neutral
    Effect size
    Small
    Dose
    100 mg/day
  • Supplementation of the patients with 100 mg Pycnogenol over a period of 12 weeks helped to reduce the dose of the calcium antagonist nifedipine in a statistically significant manner.

    Effect
    Beneficial
    Effect size
    Small
    Dose
    100 mg/day

Adverse Events Reported

  • PineOverall tolerability

    Differences in rate of side effects were not statistically significant between the two groups.

    Finding
    No significant difference
    Significant
    No
  • Pinegastrointestinal problems

    Unwanted effects observed in both groups were of mild and transient nature, such as gastrointestinal problems, vertigo, headache and nausea.

    Finding
    Reported
    Grade
    mild
  • Pineheadache

    Unwanted effects observed in both groups were of mild and transient nature, such as gastrointestinal problems, vertigo, headache and nausea.

    Finding
    Reported
    Grade
    mild
  • Pinenausea

    Unwanted effects observed in both groups were of mild and transient nature, such as gastrointestinal problems, vertigo, headache and nausea.

    Finding
    Reported
    Grade
    mild
  • Pinevertigo

    Unwanted effects observed in both groups were of mild and transient nature, such as gastrointestinal problems, vertigo, headache and nausea.

    Finding
    Reported
    Grade
    mild
Back to top